Lipocine: FDA Recommended Boxed Warning Related to Increased Risk of Adverse Cardiovascular Outcomes Be Removed From Labels of Testosterone Products
Lipocine:建議將與增加不良心血管結果風險相關的FDA推薦警示框從睾酮產品標籤中移除
Lipocine: FDA Recommended Boxed Warning Related to Increased Risk of Adverse Cardiovascular Outcomes Be Removed From Labels of Testosterone Products
Lipocine:建議將與增加不良心血管結果風險相關的FDA推薦警示框從睾酮產品標籤中移除
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因